A draft guideline by the United States Preventive Services Task Force recommends that colorectal cancer screening should begin five years earlier—at age 45 for average-risk individuals.
As the debate around Galleri, the multi-cancer detection test developed by GRAIL Inc., rages on, fueled most recently by the full-steam-ahead support it has received from regulatory and legislative bodies, NCI Director Anthony Letai has turned his attention to the available data.
